Industry ties and evidence in public comments on the FDA framework for modifications to artificial intelligence/machine learning-based medical devices: a cross sectional study
View ORCID ProfileJames A Smith, View ORCID ProfileRoxanna E Abhari, View ORCID ProfileZain U Hussain, View ORCID ProfileCarl Heneghan, View ORCID ProfileGary S Collins, View ORCID ProfileAndrew J Carr
doi: https://doi.org/10.1101/2019.12.11.19013953
James A Smith
1Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK
2National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK
Roles: postdoctoral scientist
Roxanna E Abhari
1Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK
Roles: postdoctoral scientist
Zain U Hussain
3College of Medicine and Veterinary Sciences, University of Edinburgh, UK
Roles: medical student
Carl Heneghan
4Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, UK
Roles: professor
Gary S Collins
2National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK
5Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK
Roles: professor
Andrew J Carr
1Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK
2National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK
Roles: professor
Data Availability
The data, code, and data collection protocol are available on open science framework: https://osf.io/g423d/
Posted June 18, 2020.
Industry ties and evidence in public comments on the FDA framework for modifications to artificial intelligence/machine learning-based medical devices: a cross sectional study
James A Smith, Roxanna E Abhari, Zain U Hussain, Carl Heneghan, Gary S Collins, Andrew J Carr
medRxiv 2019.12.11.19013953; doi: https://doi.org/10.1101/2019.12.11.19013953
Industry ties and evidence in public comments on the FDA framework for modifications to artificial intelligence/machine learning-based medical devices: a cross sectional study
James A Smith, Roxanna E Abhari, Zain U Hussain, Carl Heneghan, Gary S Collins, Andrew J Carr
medRxiv 2019.12.11.19013953; doi: https://doi.org/10.1101/2019.12.11.19013953
Subject Area
Subject Areas
- Addiction Medicine (319)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2330)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11676)
- Forensic Medicine (10)
- Gastroenterology (690)
- Genetic and Genomic Medicine (3667)
- Geriatric Medicine (344)
- Health Economics (629)
- Health Informatics (2354)
- Health Policy (923)
- Hematology (339)
- HIV/AIDS (767)
- Medical Education (363)
- Medical Ethics (104)
- Nephrology (395)
- Neurology (3422)
- Nursing (193)
- Nutrition (515)
- Oncology (1795)
- Ophthalmology (530)
- Orthopedics (213)
- Otolaryngology (284)
- Pain Medicine (229)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1018)
- Primary Care Research (413)
- Public and Global Health (6072)
- Radiology and Imaging (1249)
- Respiratory Medicine (818)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)